Early combination lipid-lowering therapy with high-intensity statins and ezetimibe protects against later cardiovascular ...

For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

National Risk Management Research Laboratory, Land Remediation and Pollution Control Division, Cincinnati, Ohio 45224-1701, United States ∥ Soil and Water Science Department, University of Florida, ...

Data shows Ravalli County, Mont., an area seeing explosive population and development growth, is at higher wildfire risk than ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

Dr. Angela Jia discussed How Better Treatments and Better Selection Can Improve Patient Outcomes in Localized Prostate Cancer. Dr. Jia discussed two important abstracts presented during the session: ...

In total, 55% of active tuberculosis, 99% of latent tuberculosis, 61% of hepatitis B, 35% of HIV, and 83% of hepatitis C ...

A recent study in The Journal of Gerontology analyses Medicare data from 3,588,671 Medicare beneficiaries diagnosed as having ...

Novartis is announcing data from a new subgroup analysis of the Phase III NATALEE trial evaluating the efficacy and safety of Kisqali(R) (ribociclib) plus endocrine therapy (ET, a non-steroidal ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and obesity.

China: A recent study published in the journal Gastroenterology has highlighted how alcohol consumption and genetic ...